According to LabCorp's latest financial reports the company has a price-to-book ratio of 1.86.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 2.07 | -29.4% |
2021-12-31 | 2.93 | 38.18% |
2020-12-31 | 2.12 | -2.52% |
2019-12-31 | 2.17 | 21.22% |
2018-12-31 | 1.79 | -24.6% |
2017-12-31 | 2.38 | -1.01% |
2016-12-31 | 2.40 | -5.19% |
2015-12-31 | 2.53 | -21.73% |
2014-12-31 | 3.24 | 2.97% |
2013-12-31 | 3.14 | 5.46% |
2012-12-31 | 2.98 | -11.71% |
2011-12-31 | 3.38 | -6.75% |
2010-12-31 | 3.62 | -3.25% |
2009-12-31 | 3.74 | -2.66% |
2008-12-31 | 3.84 | -20.89% |
2007-12-31 | 4.86 | 7.01% |
2006-12-31 | 4.54 | 25.7% |
2005-12-31 | 3.61 | 6.44% |
2004-12-31 | 3.39 | 21.49% |
2003-12-31 | 2.79 | 31.13% |
2002-12-31 | 2.13 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | 45.3 | 2,333.51% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | 2.42 | 29.81% | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | 2.12 | 13.87% | ๐บ๐ธ USA |
![]() Qiagen QGEN | 3.01 | 61.77% | ๐ณ๐ฑ Netherlands |
![]() Enzo Biochem ENZ | 3.35 | 79.63% | ๐บ๐ธ USA |